Equillium, Inc. (EQ)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Net income
- -22,398,000
- Operating income
- -23,634,000
- Earnings per share
- -0.39
Growth and profitability
- Return on equity
- -78.32
- Return on assets
- -70.24
Balance sheet
- Total assets
- 31,887,000
- Total liabilities
- 3,290,000
- Shareholders' equity
- 28,597,000
- Cash and equivalents
- 30,277,000
- Current ratio
- 10.58
Cash flow and ratios
- Operating cash flow
- -22,746,000
- Free cash flow
- -22,794,000
Shareholder returns
- Shares outstanding
- 82,324,700
- Book value per share
- 0.35
Company information
- Headquarters
- La Jolla, CA
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
Equillium, Inc. trades on NASDAQ under the ticker symbol EQ. This page brings together its price chart, company profile, key financial figures and technical indicators.